136 related articles for article (PubMed ID: 14749500)
41. Positive transcription elongation factor b activity in compensatory myocardial hypertrophy is regulated by cardiac lineage protein-1.
Espinoza-Derout J; Wagner M; Salciccioli L; Lazar JM; Bhaduri S; Mascareno E; Chaqour B; Siddiqui MA
Circ Res; 2009 Jun; 104(12):1347-54. PubMed ID: 19443839
[TBL] [Abstract][Full Text] [Related]
42. Three RNA polymerase II carboxyl-terminal domain kinases display distinct substrate preferences.
Ramanathan Y; Rajpara SM; Reza SM; Lees E; Shuman S; Mathews MB; Pe'ery T
J Biol Chem; 2001 Apr; 276(14):10913-20. PubMed ID: 11278802
[TBL] [Abstract][Full Text] [Related]
43. HIV-1 Tat interaction with RNA polymerase II C-terminal domain (CTD) and a dynamic association with CDK2 induce CTD phosphorylation and transcription from HIV-1 promoter.
Deng L; Ammosova T; Pumfery A; Kashanchi F; Nekhai S
J Biol Chem; 2002 Sep; 277(37):33922-9. PubMed ID: 12114499
[TBL] [Abstract][Full Text] [Related]
44. Regulation of CDK7-carboxyl-terminal domain kinase activity by the tumor suppressor p16(INK4A) contributes to cell cycle regulation.
Nishiwaki E; Turner SL; Harju S; Miyazaki S; Kashiwagi M; Koh J; Serizawa H
Mol Cell Biol; 2000 Oct; 20(20):7726-34. PubMed ID: 11003668
[TBL] [Abstract][Full Text] [Related]
45. Interaction of cyclin-dependent kinase 12/CrkRS with cyclin K1 is required for the phosphorylation of the C-terminal domain of RNA polymerase II.
Cheng SW; Kuzyk MA; Moradian A; Ichu TA; Chang VC; Tien JF; Vollett SE; Griffith M; Marra MA; Morin GB
Mol Cell Biol; 2012 Nov; 32(22):4691-704. PubMed ID: 22988298
[TBL] [Abstract][Full Text] [Related]
46. 7SK small nuclear RNA binds to and inhibits the activity of CDK9/cyclin T complexes.
Nguyen VT; Kiss T; Michels AA; Bensaude O
Nature; 2001 Nov; 414(6861):322-5. PubMed ID: 11713533
[TBL] [Abstract][Full Text] [Related]
47. P-TEFb containing cyclin K and Cdk9 can activate transcription via RNA.
Lin X; Taube R; Fujinaga K; Peterlin BM
J Biol Chem; 2002 May; 277(19):16873-8. PubMed ID: 11884399
[TBL] [Abstract][Full Text] [Related]
48. Transcriptional regulation by targeted recruitment of cyclin-dependent CDK9 kinase in vivo.
Majello B; Napolitano G; Giordano A; Lania L
Oncogene; 1999 Aug; 18(32):4598-605. PubMed ID: 10467404
[TBL] [Abstract][Full Text] [Related]
49. T-loop phosphorylated Cdk9 localizes to nuclear speckle domains which may serve as sites of active P-TEFb function and exchange between the Brd4 and 7SK/HEXIM1 regulatory complexes.
Dow EC; Liu H; Rice AP
J Cell Physiol; 2010 Jul; 224(1):84-93. PubMed ID: 20201073
[TBL] [Abstract][Full Text] [Related]
50. Regulation of CAK kinase activity by p53.
Schneider E; Montenarh M; Wagner P
Oncogene; 1998 Nov; 17(21):2733-41. PubMed ID: 9840937
[TBL] [Abstract][Full Text] [Related]
51. Endothelin-1-induced cardiomyocyte hypertrophy is partly regulated by transcription factor II-F interacting C-terminal domain phosphatase of RNA polymerase II.
Sakai S; Kimura T; Wang Z; Shimojo N; Maruyama H; Homma S; Kuga K; Yamaguchi I; Aonuma K; Miyauchi T
Life Sci; 2012 Oct; 91(13-14):572-7. PubMed ID: 22569295
[TBL] [Abstract][Full Text] [Related]
52. Interactions between fission yeast Cdk9, its cyclin partner Pch1, and mRNA capping enzyme Pct1 suggest an elongation checkpoint for mRNA quality control.
Pei Y; Schwer B; Shuman S
J Biol Chem; 2003 Feb; 278(9):7180-8. PubMed ID: 12475973
[TBL] [Abstract][Full Text] [Related]
53. Interaction between P-TEFb and the C-terminal domain of RNA polymerase II activates transcriptional elongation from sites upstream or downstream of target genes.
Taube R; Lin X; Irwin D; Fujinaga K; Peterlin BM
Mol Cell Biol; 2002 Jan; 22(1):321-31. PubMed ID: 11739744
[TBL] [Abstract][Full Text] [Related]
54. Cdk-activating kinase complex is a component of human transcription factor TFIIH.
Shiekhattar R; Mermelstein F; Fisher RP; Drapkin R; Dynlacht B; Wessling HC; Morgan DO; Reinberg D
Nature; 1995 Mar; 374(6519):283-7. PubMed ID: 7533895
[TBL] [Abstract][Full Text] [Related]
55. TFIIH inhibits CDK9 phosphorylation during human immunodeficiency virus type 1 transcription.
Zhou M; Nekhai S; Bharucha DC; Kumar A; Ge H; Price DH; Egly JM; Brady JN
J Biol Chem; 2001 Nov; 276(48):44633-40. PubMed ID: 11572868
[TBL] [Abstract][Full Text] [Related]
56. Separate domains of fission yeast Cdk9 (P-TEFb) are required for capping enzyme recruitment and primed (Ser7-phosphorylated) Rpb1 carboxyl-terminal domain substrate recognition.
St Amour CV; Sansó M; Bösken CA; Lee KM; Larochelle S; Zhang C; Shokat KM; Geyer M; Fisher RP
Mol Cell Biol; 2012 Jul; 32(13):2372-83. PubMed ID: 22508988
[TBL] [Abstract][Full Text] [Related]
57. Association of Cdk-activating kinase subunits with transcription factor TFIIH.
Serizawa H; Mäkelä TP; Conaway JW; Conaway RC; Weinberg RA; Young RA
Nature; 1995 Mar; 374(6519):280-2. PubMed ID: 7885450
[TBL] [Abstract][Full Text] [Related]
58. The structure of P-TEFb (CDK9/cyclin T1), its complex with flavopiridol and regulation by phosphorylation.
Baumli S; Lolli G; Lowe ED; Troiani S; Rusconi L; Bullock AN; Debreczeni JE; Knapp S; Johnson LN
EMBO J; 2008 Jul; 27(13):1907-18. PubMed ID: 18566585
[TBL] [Abstract][Full Text] [Related]
59. Hyperphosphorylation of the C-terminal repeat domain of RNA polymerase II facilitates dissociation of its complex with mediator.
Søgaard TM; Svejstrup JQ
J Biol Chem; 2007 May; 282(19):14113-20. PubMed ID: 17376774
[TBL] [Abstract][Full Text] [Related]
60. Three cyclin-dependent kinases preferentially phosphorylate different parts of the C-terminal domain of the large subunit of RNA polymerase II.
Pinhero R; Liaw P; Bertens K; Yankulov K
Eur J Biochem; 2004 Mar; 271(5):1004-14. PubMed ID: 15009212
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
